A Randomized, Multicentre, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Oesophageal or Gastroesophageal Junction Cancer

Lau, David (Primary Chief Investigator (PCI))
Strickland, Andrew (Primary Chief Investigator (PCI))
Strickland, Andrew (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA Reference Number: HREC/16/MonH/118
Monash Health HREC Ref: 16208A

Status	Active
Effective start/end date	8/02/19 → 27/09/26